alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,826–6,850 of 7,816 matching trials · page 274 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Social Interactions Between People With Dementia in Nursing Home
NCT02403245
Psychosocial stimulation 		NA
other		 COMPLETED 60 Paris West University Nanterre La Défense
OTHER		 2015-03-31
Minocycline in Patients With Huntington's Disease
NCT00029874
Minocycline
Runs in: United States · 1 site 		PHASE1|PHASE2
anti-inflammatory		 COMPLETED 63 FDA Office of Orphan Products Development
OTHER_GOV		 2015-03-25
Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients
NCT01485302
SAR228810; SAR228810
Runs in: Bulgaria; France; Netherlands; South Africa; Sweden · 8 sites 		PHASE1
other		 COMPLETED 48 Sanofi
INDUSTRY		 2015-03-25
A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
NCT02178124
Donepezil; placebo
Runs in: South Korea · 1 site 		PHASE1
symptomatic-cholinergic		 COMPLETED 24 Icure Pharmaceutical Inc.
INDUSTRY		 2015-03-25
Intervention Programs for Decreasing Caregiver Burden in Caregivers of Patients With Dementia
NCT02397980
Behavioral intervention 		NA
other		 UNKNOWN 80 Ewha Womans University Mokdong Hospital
OTHER		 2015-03-25
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
NCT00174382
Donepezil
Runs in: Canada · 30 sites 		PHASE3
symptomatic-cholinergic		 TERMINATED 149 Pfizer
INDUSTRY		 2015-03-24
A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease
NCT01122329
caprylidene; Placebo
Runs in: United States · 2 sites 		PHASE4
other		 COMPLETED 17 University of California, Los Angeles
OTHER		 2015-03-23
Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
NCT01397539
BIIB037; Placebo
Runs in: United States · 3 sites 		PHASE1
other		 COMPLETED 53 Biogen
INDUSTRY		 2015-03-23
A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175
NCT00096824
Neurological assessment
Runs in: Brazil; India; Malawi; South Africa; Zimbabwe · 11 sites 		NA
other		 COMPLETED 860 Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK		 2015-03-18
Group Intervention Empowerment Dementia
NCT02391766
empowerment; usual care
Runs in: Argentina · 1 site 		EARLY_PHASE1
other		 UNKNOWN 180 Universidad Nacional de Rosario
OTHER		 2015-03-18
Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
NCT00594568
LY450139; Placebo
Runs in: Argentina; Australia; Belgium; Canada; Chile; Denmark; Fi... · 148 sites 		PHASE3
other		 COMPLETED 1,537 Eli Lilly and Company
INDUSTRY		 2015-03-17
Ammonia Levels and Cognitive Impairment
NCT02059356
Runs in: United States · 1 site 		NA
other		 TERMINATED 17 Duke University
OTHER		 2015-03-17
Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
NCT00290082
loxapine, midazolam; blood sample; patient monitoring; Loxapine; Midazolam
Runs in: France · 21 sites 		PHASE3
other		 TERMINATED 120 University Hospital, Rouen
OTHER		 2015-03-11
Effects of Strengthening Exercise on the Brain for Early Dementia and Normative Older Adults
NCT01264614
Strengthening exercise
Runs in: United States · 1 site 		NA
other		 COMPLETED 22 Union College, New York
OTHER		 2015-03-11
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease
NCT00691340 		NA
other		 WITHDRAWN 0 University Hospital, Basel, Switzerland
OTHER		 2015-03-10
Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET Imaging
NCT01815112
Magnetic resonance imaging; Positron emission tomography
Runs in: France · 2 sites 		NA
other		 TERMINATED 60 Centre Hospitalier Universitaire, Amiens
OTHER		 2015-03-10
A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes
NCT00630851
Donepezil (Aricept); Placebo
Runs in: Sweden · 53 sites 		PHASE3
symptomatic-cholinergic		 COMPLETED 249 Pfizer
INDUSTRY		 2015-03-05
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease
NCT01481961
repetitive Transcranial Magnetic Stimulation (rTMS)
Runs in: France · 1 site 		NA
other		 COMPLETED 15 Pierre Vandel, MD PhD
OTHER		 2015-03-03
Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction
NCT01554475
Runs in: Norway · 1 site 		NA
other		 COMPLETED 151 University Hospital of North Norway
OTHER		 2015-02-18
Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
NCT00762411
LY450139; Placebo
Runs in: Brazil; Bulgaria; Canada; China; France; Germany; Hungary... · 91 sites 		PHASE3
other		 COMPLETED 1,111 Eli Lilly and Company
INDUSTRY		 2015-02-16
Study of Electroconvulsive Therapy (ECT) Treatment for Agitation and Aggression in Dementia
NCT01856010
ECT treatment; Standard Care (Non-ECT group)
Runs in: United States · 2 sites 		NA
other		 COMPLETED 23 Pine Rest Christian Mental Health Services
OTHER		 2015-02-16
Assessment of an Automated Telesurveillance System on Serious Falls Prevention in an Elderly Suffering From Dementia Specialized Care Unit: the URCC
NCT01561872
Runs in: France · 1 site 		NA
other		 COMPLETED 350 University Hospital, Limoges
OTHER		 2015-02-13
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)
NCT00420420
MK0249; Comparator: Placebo (unspecified) 		PHASE2
other		 COMPLETED 144 Merck Sharp & Dohme LLC
INDUSTRY		 2015-02-12
A Safety Study of TTP4000 in Subjects With Alzheimer's Disease
NCT01548430
TTP4000; Placebo
Runs in: United States · 3 sites 		PHASE1
other		 COMPLETED 8 vTv Therapeutics
INDUSTRY		 2015-02-12
Amyloïd Load in Elderly Population: Effect of Cognitive Reserve
NCT02196116
PET; MRI; neuropsychological tests
Runs in: France · 1 site 		NA
other		 UNKNOWN 120 University Hospital, Bordeaux
OTHER		 2015-02-12

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →